PTK2 and renal cell carcinoma: FAK is a multifunctional regulator of cell signalling in various tumours and promotes cell motility, survival and proliferation.28,29 Overexpressing FAK reduced sorafenib effectiveness in RCC cells (Supplementary Figure 5A, B) and FAK knockdown improved the sorafenib sensitivity of RCC cells (Supplementary Figure 5C).